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Abstract
Maximal expiratory flow rates such as Peak Expiratory Flow Rate (PEFR), rates
at 25%, 50% and 75% of forced vital capacity (VE 25%, VE 50% and VE 75%)
were studied in twenty untreated tropical eosinophilia (TE) patients. All
measurements were significantly lower in patients with TE compared to their mean
predicted values. These data suggest that inflammation of airways is an important
mechanism of pathophysiology of tropical eosinophilia.
Introduction
The pulmonarymanifestations of
tropical eosinophilia (TE) are
characterized bycough, dyspnoea,
nocturnal wheezing and diffuse
reticula-nodular infiltrates on chest X-rays
(Udwadia, 1964).Pulmonary function
studies (Vijayan et al., 1991; Nesarajiah,
1972; Ray, 1974) had shown restrictive and
obstructive ventilatory defects.
Histopathological studies had revealed
(Udwadia, 1967) dense accumulation of
eosinophils in interstitial tissue. A striking
eosinophilic alveolitis with marked
elevation in both the proportion and
concentrationof eosinophils in the
recovered fluid has also been described by
bronchoalveolar lavage studies (Pinkston
et al., 1987). The lung function
abnormalities in TE could, therefore, be
due to the abnormally accumulated
inflammatory cells in the lung. The
maximal expiratory flow rates during
forced vital capacity manoeuvre had been
shown to reflect histopathological changes
in lungs (Cosio et al., 1978). Thus, in
conformity with these findings, we had
previously shown that there was a
correlation between lung function changes
and lower respiratory tract inflammation
(Vijayan et al., 1991). However, there are
no reported studies of maximal expiratory
f low rates  in  untreated Tropica l
Eosinophilia patients.Therefore, we
undertook a study to evaluate changes in
maximal expiratory flow rates and their
rel tionship with peripheral  blood
eosi ophilia.
Materials and Methods
Twenty male patients with symptoms
of one week to six months duration and
fulfilling the diagnostic criteria (Neva et
al., 1978) of residence in the endemic area
of Madras city, respiratory symptoms such
as cough, dyspnoea and nocturnal 
whe zing, chest X-ray infiltrates,
peripheral blood eosinophilia of more than
2000 cells per cubic millimeters, high
serum titres of antifilarial IgG and a
respo se to diethylcarbamazine therapy
wer  included in the study. Clinical
evaluation of each patientincluded
detailed history, physical examination,
chest x-ray, blood and stool examinations
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for the presence of other parasites and IgG
filarial antibody determinations.
Maximal flow volume spirogram tests
were carried out using Transfer Test
Model C (P.K. Morgan P. Ltd. Chatham
UK). This instrument is provided with
Data Dee Computer and X-Y recorder for
electronic memory and recording flow
volume loops.The instrument has a
resolution of 0.05 litre in measuring lung
volume and 0.1 litre per second in
measuring flow rates.
The results are printed out after
correction to body temperature and
pressure saturated with water vapour
 (BTPS). Best of three well attempted
efforts is utilised for analysis of Forced
Vital Capacity (FVC) and Forced
Expiratory Volume in one second. The
highest value of peak expiratory flow
(PEFR) in any of the attempts, and values
of flow rates at 25% (VE25), 50% (VE50);
75% (VE75) of vital capacity obtained
from the attempt in which the sum of FVC
and FEV1 was highest, were used for
further statistical analysis (American
Thoracic Society Workshop Report, 1979).
The predicted values of maximal
expiratory flow rates for this study were
obtained from the regression equations
established in our laboratory (Vijayan et
al., in press). Total and differential
leucocyte counts were utilised to obtain
blood eosinophils. Data were analysed by
the students t-test.
Results
Of the twenty male patients, nine were
smokers andremaining 11 were
non-smokers: The mean age was 22.7±5
(SD) years (range 18 - 40 years). Mean
height was 163.1±6.5 (SD) centimeters
and mean weight was 46.7±8.0(SD)
ki logrammes. 
Since there was no significant
difference in mean values of maximal
expiratory flow measurements between
smokers and non- smokers, the data were
amalgamated.Spirometric lung volumes
re shown in Table 1.The maximal
expiratory flow rates, viz, PEFR VE 25%,
VE50% and VE75% are as given in Table
2.
Table 1: Spirometric Lung Volumes
Table 2 Maximal Expiratory Flow Rates in TE
* P<0.01 ** P<.001
PEFR (5.25±1.71 L/S VS 6.74±0.68
L/S P < 0.001); VE25% (4.08±1.66 L/S VS
5.44±0.62 L/S P< 0.01); VE50% (2.77±
1.02 L/S VS 3.72 ±0.42 L/S P < 0.001) and
VE 75% (1.28±0.90 L/S VS 1.92±0.32
L/S P< 0.01) were significantly lower in
patients compared to their mean predicted
values (Fig.1). PEFR was less than 70%
predicted in 6 patients, VE 25%, VE 50%
and VE 75% were less than 70% predicted
in 8, 8 and 12 patients respectively.
On further analysis it was found that
there was no correlation between any of
the expiratory flow rates and peripheral
blood eosinophilia.
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Discussion
The predominant pulmonary function
abnormality in untreated TE had been
shown to be a reduction in single breath
transfer factor (Vijayan et al., 1988) and a
proportion of patients had obstructive
ventilatory defects as well (Vijayan et al.,
1991). The observation of significantly
reduced expiratory flow rates in our study
subjects suggeststhe involvement of
airways in the inflammatory process in
addition to parenchymal inflammation.
The lower respiratory tract inflammation
in untreated TE had been shown to be due
to an intense macrophage-eosinophilic
alveolitis (Vijayan et al., 1991). We had
also shownthat inflammatorycells
especially macrophages recovered from
lower respiratory tract had negative
correlation with pulmonoary function tests
such as FVC and FEV1 (Vijayan et al.,
1991). Therefore, signficant reductions in
expiratory flow rates in this study may
suggest that inflammation of airway may
also play an important role in
pathophysiology of the disease.
VE 50% VE 75%
FLOW
Activated eosinophils had been shown
to be capable of injuring airways and
parenchymal cells (Barnes et al., 1987;
Davis et al., 1984; Frigas et al., 1980).
Eventhough there was no correlation of
peripheral blood eosinophils with flow
rates in this study, the abnormally
acumulated lung eosinophils may cause
injury to airway epithelium; as it had been
shown that eosinophilic cationic protein
and major basic protein released from
activated eosinophils arecapable of
injuring airway epithelium in subjects with
bronchial asthma and Adult Respiratory
Distress Syndrome (Hallgren et al., 1987;
Laitenen et al., 1985). Inflammatory cells
recovered from lower respiratory tract
have been shown to be capable of
releasing various inflammatory mediators
such as Platelet Activating Factor (PAF),
leukotrines, histamine and prostaglandins
(Barnes et al., 1987).We had shown
previously that the eosinophils recovered
from the lower respiratory tract of patients
with untreated TE are activated (Pinkston
et al., 1987) and thus capable of releasing
toxic mediators. It had also been shown
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that there was airway hyperreactivity in TE
(Chhabra et al., 1988) and the mechanism
of this hyperresponsiveness in TE may be
due to the toxic mediators especially PAF
produced by these inflammatory cells
(Barnes et al., 1987; Lee et al., 1984).
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